VTE VENOUS THROMBOEMBOLISM

38
ALMANA GROUP OF HOSPITALS VENOUS THROMBOEMBOLISM VTE DAMMAM Dr. AHMED ELAMIN AWADELKARIM MEDICAL RESIDENT AHMEDELAMINELSIDDIG

Transcript of VTE VENOUS THROMBOEMBOLISM

Page 1: VTE VENOUS THROMBOEMBOLISM

ALMANA GROUP OF HOSPITALS

VENOUS THROMBOEMBOLISM

VTE

DAMMAM

Dr. AHMED ELAMIN AWADELKARIM

MEDICAL RESIDENT

AHMEDELAMINELSIDDIG

Page 2: VTE VENOUS THROMBOEMBOLISM

OBJECTIVES Overview of VTE. Risk factors. Scoring systems. DVT diagnosis and management. PE diagnosis and management. Special situations.

Page 3: VTE VENOUS THROMBOEMBOLISM

overview

Medical education does not exist to provide students with away of making living, but to ensure the health of the community.

Rudolf Calr Virchow

Page 4: VTE VENOUS THROMBOEMBOLISM

overview

Page 5: VTE VENOUS THROMBOEMBOLISM

DVT

Internal Medicine Dpt.

Page 6: VTE VENOUS THROMBOEMBOLISM

DVTClassic symptoms includes:

oUnilateral Limb pain and tenderness this may be along the line of the vein.oGeneralized swelling (edematous) of the calf/thigh (unilateral).oHot, erythematous skin.oThere may also be distension of the superficial veins.

Internal Medicine Dpt.

Page 7: VTE VENOUS THROMBOEMBOLISM
Page 8: VTE VENOUS THROMBOEMBOLISM

Well’s score for DVT

Internal Medicine Dpt.

Page 9: VTE VENOUS THROMBOEMBOLISM

DIFFERENTIAL DIAGNOSIS•Muscle strain/hematoma•Popliteal cyst•Lymphedema•Cellulitis•Fracture•Chronic venous insufficiency•Proximal venous compression (e.g. tumor)•Congestive heart failure

Internal Medicine Dpt.

Page 10: VTE VENOUS THROMBOEMBOLISM

D-DIMER negative- DVT is highly unlikely (High sensitivity).  

However positive- it DOES NOT CONFIRM DVT 

may be raised in patients with liver disease rheumatoid diseaseInflammationCancerTrauma pregnancy recent surgery

Internal Medicine Dpt.

Page 11: VTE VENOUS THROMBOEMBOLISM

Nice guidance for DVT

Internal Medicine Dpt.

Page 12: VTE VENOUS THROMBOEMBOLISM

Pulmonary Embolism P.E

Internal Medicine Dpt.

Page 13: VTE VENOUS THROMBOEMBOLISM

OVERVIEW600.000 case per year.50.000 deaths per year.Tests is done too much …negative.Most of cases are missed ….autopsy.

Internal Medicine Dpt.

Page 14: VTE VENOUS THROMBOEMBOLISM

IN ADDITION PREVIOUS DVT

Internal Medicine Dpt.

Page 15: VTE VENOUS THROMBOEMBOLISM

OVERVIEWClot travels from deep veins, RV then pulmonary arteries

Blood flow obstructed

Tissue necrosis

Symptoms result

Internal Medicine Dpt.

Page 16: VTE VENOUS THROMBOEMBOLISM

PRESENTATIONShortness of breathChest pain (+/- pleuritic)SyncopeHemoptysisMay mimic pneumonia (if lung infarction)TachycardiaHypoxiaElevated JVP (or distended jugular veins)DVT symptoms

Internal Medicine Dpt.

Page 17: VTE VENOUS THROMBOEMBOLISM

WELL’S SCORE FOR PE

Internal Medicine Dpt.

Page 18: VTE VENOUS THROMBOEMBOLISM

NICE GUIDANCE FOR PE

Internal Medicine Dpt.

Page 19: VTE VENOUS THROMBOEMBOLISM

ABGshypoxemia and hypocapnea (respiratory

alkalosis) due to hyperventilation,

keep in mind arterial blood gas analysis is NOT useful in diagnosis of pulmonary embolism.

Classic finding: hypoxemia and hypocapnea (respiratory alkalosis).Normal ABG: 18% will have PaO2 > 85 mm Hg.Mixed Acidosis: in setting of hemodynamic collapse.

Internal Medicine Dpt.

Page 20: VTE VENOUS THROMBOEMBOLISM

Blood InvestigationsFBC (Check WCC)CRPU&Es (check for any signs of electrolyte imbalance or kidney failure which may prevent CTPA)LFTs (check for liver failure that may cause bleeding abnormalities of be a sign of cancer)coagulation screenTroponins could also be considered.

Internal Medicine Dpt.

Page 21: VTE VENOUS THROMBOEMBOLISM

ECG CHANGES• sinus tachycardia• Complete or incomplete RBBB (tall R wave in V1 ‘M’; slurred S

wave in V6 ‘W’;MaRRoW)• Right ventricular strain- T wave inversions in right (v1-4)

and inferior (II, III, aVF) leads• Right axis deviation (negative QRS in lead I and aVL and

positive in lead III and aVF)• right ventricular dilation (Dominant R wave in V1 )• Right atrial enlargement (P pulmonale) (>2.5mm peaked P

waves in inferior leads (II, III and aVF) and >1.5mm peaked P wave in V1 and V2)

• S1Q3T3 pattern: deep S wave in lead I, Q wave in III, and inverted T wave in lead III.

Internal Medicine Dpt.

Page 22: VTE VENOUS THROMBOEMBOLISM

SINUS TACHY+RBBB+T INVERSION V1-3

Internal Medicine Dpt.

Page 23: VTE VENOUS THROMBOEMBOLISM

RBBB+S1Q3T3+R axis deviation

Internal Medicine Dpt.

Page 24: VTE VENOUS THROMBOEMBOLISM

chest x-ray

NORMAL

HAMPTON’S SIGN

WESTERMARK’S SIGN

Internal Medicine Dpt.

Page 25: VTE VENOUS THROMBOEMBOLISM

Internal Medicine Dpt.

Page 26: VTE VENOUS THROMBOEMBOLISM

Internal Medicine Dpt.

Page 27: VTE VENOUS THROMBOEMBOLISM

Internal Medicine Dpt.

Page 28: VTE VENOUS THROMBOEMBOLISM

CTPA

Internal Medicine Dpt.

Page 29: VTE VENOUS THROMBOEMBOLISM

VQ SCAN

Internal Medicine Dpt.

Page 30: VTE VENOUS THROMBOEMBOLISM

Management

Internal Medicine Dpt.

Page 31: VTE VENOUS THROMBOEMBOLISM

Management

Internal Medicine Dpt.

Page 32: VTE VENOUS THROMBOEMBOLISM

ManagementShould I start?? Which one??Appropriate dose??How I monitor??How long??

Patient is stable or not??

Page 33: VTE VENOUS THROMBOEMBOLISM

ManagementFor massive PE, thrombolyse unless there are any contraindications Alteplase 50mg stat IV (if imminent cardiac arrest) or 10mg stat IV then 90mg infusion over 120mins

Contraindications includeMajor surgery/trauma in previous 2 weeks; aortic dissection; acute internal bleeding; known cerebral tumour; hx of cerebral bleed/AVM; prolonged/traumatic CPR; pregnancyRelative CI include BP>180/110mmHg; severe renal/liver failure; INR>1.5 from warfarin use or liver disease; current use of warfarin with unknown INR; current use of rivaroxiban; stroke/TIA in last 12 months

Internal Medicine Dpt.

Page 34: VTE VENOUS THROMBOEMBOLISM

ManagementNewer agents (mainly factor Xa inhibitors e.g. rivaroxaban)

are now being used in treating DVT/PE15mg BD for 3 weeks then 20mg BD until 3 or 6 months

(provoked/unprovoked respectively)Not used if eGFR<30

not used for >12 months – consider warfarin in those requiring longer term anticoagulation

Offer low molecular weight heparin injection e.g. dalteparin (usually 10000-15000 units per day- based on weight), (or

fondaparinux) to those unsuitable for rivaroxiban

Internal Medicine Dpt.

Page 35: VTE VENOUS THROMBOEMBOLISM

ManagementAlso, unfractionated heparin may be preferred in patients with severe renal failure or are haemodynamically unstable.Continue for 5 days or until the INR has been >2 for at least 24 hours (whichever is longer).In patients with cancer, ideally LMWH should be continued for 6 monthsOffer a vitamin K antagonist e.g. warfarin, within 24 hours and continue for 3 months minimum. (see warfarin prescribing)Reassess risk at 3 months- consider further 3 months, particularly if the DVT/PE was unprovoked

Internal Medicine Dpt.

Page 36: VTE VENOUS THROMBOEMBOLISM

PREVENTIONAGH POLICY

Internal Medicine Dpt.

Page 37: VTE VENOUS THROMBOEMBOLISM
Page 38: VTE VENOUS THROMBOEMBOLISM

THANK YOU

FOLLOW AHMEDELAMINELSIDDIG

Internal Medicine Dpt.